BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2429104)

  • 1. The molecular actions of beta-agonists in the cardiac sarcolemma.
    Harris P; Harding SE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 3():S10-1. PubMed ID: 2429104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone sensitivity of adenylate cyclase activity in cardiac sarcolemma and sarcoplasmic reticulum preparations.
    Reiss DS; Katz AM
    J Mol Cell Cardiol; 1979 Oct; 11(10):1095-107. PubMed ID: 42804
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-adrenergic hormone-receptor interactions in the hypertrophied and failing myocardium.
    Limas CJ; Limas C
    Eur Heart J; 1984 Dec; 5 Suppl F():329-37. PubMed ID: 6152424
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptor-independent activation of cardiac adenylyl cyclase by GDP and membrane-associated nucleoside diphosphate kinase. A new cardiotonic mechanism?
    Niroomand F; Mura R; Jakobs KH; Rauch B; Kübler W
    J Mol Cell Cardiol; 1997 May; 29(5):1479-86. PubMed ID: 9201632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma membrane-associated nucleoside diphosphate kinase (nm23) in the heart is regulated by beta-adrenergic signaling.
    Lutz S; Mura RA; Hippe HJ; Tiefenbacher C; Niroomand F
    Br J Pharmacol; 2003 Nov; 140(6):1019-26. PubMed ID: 14559858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac adenylate cyclase activity in relation to beta-adrenergic responses.
    Wollemann M; Borbola J; Papp J; Szekeres L
    J Mol Cell Cardiol; 1975 Jul; 7(7):523-33. PubMed ID: 239250
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical physiology of adrenergic receptor regulation.
    Lefkowitz RJ
    Am J Physiol; 1982 Jul; 243(1):E43-7. PubMed ID: 6124130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propofol attenuates beta-adrenoreceptor-mediated signal transduction via a protein kinase C-dependent pathway in cardiomyocytes.
    Kurokawa H; Murray PA; Damron DS
    Anesthesiology; 2002 Mar; 96(3):688-98. PubMed ID: 11873046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of adenylate cyclase by adenosine and other agonists in rat myocardial sarcolemma.
    Anand-Srivastava MB
    Arch Biochem Biophys; 1985 Dec; 243(2):439-46. PubMed ID: 2417561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced responsiveness of the myocardial beta-adrenoceptor-adenylate cyclase system in the perfused rat heart (I).
    Gordeladze JO; Jynge I; Borchgrevink PC; Sellevold OF
    Biosci Rep; 1998 Oct; 18(5):229-50. PubMed ID: 10192281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective response to cAMP-dependent protein kinase in non-insulin-dependent diabetic heart.
    Schaffer SW; Allo S; Punna S; White T
    Am J Physiol; 1991 Sep; 261(3 Pt 1):E369-76. PubMed ID: 1653526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of cardiac sodium-calcium exchanger by beta-adrenergic agonists.
    Fan J; Shuba YM; Morad M
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5527-32. PubMed ID: 8643609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cardiac EP3 receptors by PGE1 reduces beta-adrenergic inotropic effects.
    Hohlfeld T; Schrör K
    Adv Exp Med Biol; 1997; 433():447-50. PubMed ID: 9561192
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular and functional properties of beta-adrenergic receptors.
    Strosberg AD
    Am J Cardiol; 1987 May; 59(13):3F-9F. PubMed ID: 2883875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations of the cAMP-adenylate cyclase system in the failing human heart. Consequences for the therapy with inotropic drugs].
    Böhm M; Schwinger RH; Erdmann E
    Klin Wochenschr; 1990 Sep; 68(18):887-95. PubMed ID: 1979643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic function in heart muscle disease and heart failure.
    Bristow MR; Kantrowitz NE; Ginsburg R; Fowler MB
    J Mol Cell Cardiol; 1985 Jul; 17 Suppl 2():41-52. PubMed ID: 2863387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unifying model of current concepts and data on adenylate cyclase activation by beta-adrenergic agonists.
    Swillens S; Dumont JE
    Life Sci; 1980 Sep; 27(12):1013-28. PubMed ID: 6106873
    [No Abstract]   [Full Text] [Related]  

  • 18. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure.
    Brodde OE; Hillemann S; Kunde K; Vogelsang M; Zerkowski HR
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S164-74. PubMed ID: 1355362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid peptide receptor stimulation reverses beta-adrenergic effects in rat heart cells.
    Xiao RP; Pepe S; Spurgeon HA; Capogrossi MC; Lakatta EG
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H797-805. PubMed ID: 9124441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart.
    Pepe S; Xiao RP; Hohl C; Altschuld R; Lakatta EG
    Circulation; 1997 Apr; 95(8):2122-9. PubMed ID: 9133523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.